Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 207

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Multiplex Analysis of Serum Cytokines in Melanoma Patients Treated with Interferon-α2b

Yurkovetsky, Zoya R., Kirkwood, John M., Edington, Howard D., Marrangoni, Adele M., Velikokhatnaya, Lyudmila, Winans, Matthew T., Gorelik, Elieser, Lokshin, Anna E. · 2007 · Clinical Cancer Research

Abstract

Purpose: Interferon (IFN)-α2b is the only Food and Drug Administration–approved treatment for operable high-risk melanoma that has been shown to significantly and durably prolong relapse-free survival (RFS) of patients with stage IIB-III melanoma. Development of reliable serum assays may contribute to the development of methods for earlier detection of melanoma and the selection of patients who may be most susceptible to current available interventions with IFNα. Experimental Design: A powerful high-throughput xMAP multiplex immunobead assay technology (Luminex Corp., Austin, TX) was used to simultaneously test 29 cytokines, chemokines, angiogenic as well as growth factors, and soluble receptors in the sera of 179 patients with high-risk melanoma and 378 healthy individuals. Results: Serum concentrations of interleukin (IL)-1α, IL-1β, IL-6, IL-8, IL-12p40, IL-13, granulocyte colony-stimulating factor, monocyte chemoattractant protein 1 (MCP-1), macrophage inflammatory protein (MIP)-1α, MIP-1β, IFNα, tumor necrosis factor (TNF)-α, epidermal growth factor, vascular endothelial growth factor (VEGF), and TNF receptor II were found to be significantly higher in patients with resected high-risk melanoma compared with healthy controls. Bayesian Network algorithm classification of the data offered 90% sensitivity at 98% specificity with 96.5% of melanoma patients distinguished from healthy individuals. IFN-α2b therapy resulted in a significant decrease of serum levels of immunosuppressive and tumor angiogenic/growth stimulatory factors (VEGF, epidermal growth factor, and hepatocyte growth factor) and increased levels of antiangiogenic IFN-γ inducible protein 10 (IP-10) and IFN-α. Pretreatment levels of proinflammatory cytokines IL-1β, IL-1α, IL-6, TNF-α, and chemokines MIP-1α and MIP-1β were found to be significantly higher in the serum of patients with longer RFS values of 1 to 5 and >5 years when compared with patients with shorter RFS of <1 year. Conclusion: These data show that multiplexed analysis of serum biomarkers is useful for the evaluation of prognostic markers of clinical outcome and potential predictive markers of response to IFN-α2b in patients with high-risk operable melanoma.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-06-1805

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 207

Metadata

Authors
Yurkovetsky, Z. R., Kirkwood, J. M., Edington, H. D., Marrangoni, A. M., Velikokhatnaya, L., Winans, M. T., Gorelik, E., & Lokshin, A. E.
Venue
Clinical Cancer Research
Published
2007-04-15
Volume
13
Issue
8
Pages
2422-2428
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W2116871245
Cited by
207
References
1
FWCI
8.90
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Multiplex Analysis of Serum Cytokines in Melanoma Patients Treated with Interferon-α2b. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-06-1805
The paper
Yurkovetsky, Z. R., Kirkwood, J. M., Edington, H. D., Marrangoni, A. M., Velikokhatnaya, L., Winans, M. T., Gorelik, E., & Lokshin, A. E. (2007). Multiplex Analysis of Serum Cytokines in Melanoma Patients Treated with Interferon-α2b. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-06-1805

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.